Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
A Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ACE-031 in Healthy Postmenopausal Women
This study has been completed.
Study NCT00952887 Information provided by Acceleron Pharma, Inc.
First Received on August 4, 2009. Last Updated on March 22, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Nervous System Diseases
Pathological Conditions, Anatomical
Signs and Symptoms
Interventions listed in this trial
Sponsors listed in this trial
Acceleron Pharma, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers